Efficient Synthesis of (R)-6-Benzyloxycarbonylamino-1-methyl-4-(3-methylbenzyl)hexahydro-1, 4-diazepine. I

An efficient and practical method for large scale synthesis of (R)-6-benzyloxycarbonylamino-1-methyl-4-(3-methylbenzyl)hexahydro-1, 4-diazepine (R-3), which is a key intermediate in the synthesis of DAT-582, a potent and selective serotonin-3 receptor antagonist, is described. The precursor of R-3,...

Full description

Saved in:
Bibliographic Details
Published inChemical & pharmaceutical bulletin Vol. 46; no. 7; pp. 1160 - 1164
Main Authors HARADA, Hiroshi, MORIE, Toshiya, KATO, Shiro
Format Journal Article
LanguageEnglish
Published TOKYO The Pharmaceutical Society of Japan 1998
Pharmaceutical Soc Japan
Maruzen
Japan Science and Technology Agency
Subjects
Online AccessGet full text

Cover

Loading…
Abstract An efficient and practical method for large scale synthesis of (R)-6-benzyloxycarbonylamino-1-methyl-4-(3-methylbenzyl)hexahydro-1, 4-diazepine (R-3), which is a key intermediate in the synthesis of DAT-582, a potent and selective serotonin-3 receptor antagonist, is described. The precursor of R-3, the (S)-2, 3-diaminopropylaminoacetate S-5, was obtained from the chiral triaminopropane derivative R-19. Nucleophilic reaction of the chiral mesylate R-11 with 3-methylbenzylamine gave the racemic 2, 3-diaminopropylaminoacetate (±)-5 via the achiral azetidinium cation 12, while the reaction of the N-protected mesylate R-14 produced the desired triamine S-15 but in poor yield.However, reaction of the N-protected mesylate S-18 with a large excess of methylamine proceeded smoothly to afford R-19 in good yield. S-5 was converted into R-3 with >99% enantiomeric excess using an intramolecular reductive cyclization method.
AbstractList An efficient and practical method for large scale synthesis of (R)-6-benzyloxycarbonylamino-1-methyl-4-(3-methylbenzyl)hexahydro-1, 4-diazepine (R-3), which is a key intermediate in the synthesis of DAT-582, a potent and selective serotonin-3 receptor antagonist, is described. The precursor of R-3, the (S)-2, 3-diaminopropylaminoacetate S-5, was obtained from the chiral triaminopropane derivative R-19. Nucleophilic reaction of the chiral mesylate R-11 with 3-methylbenzylamine gave the racemic 2, 3-diaminopropylaminoacetate (±)-5 via the achiral azetidinium cation 12, while the reaction of the N-protected mesylate R-14 produced the desired triamine S-15 but in poor yield.However, reaction of the N-protected mesylate S-18 with a large excess of methylamine proceeded smoothly to afford R-19 in good yield. S-5 was converted into R-3 with >99% enantiomeric excess using an intramolecular reductive cyclization method.
An efficient and practical method for large scale synthesis of (R)-6-benzyloxycarbonylamino-1-methyl-4-(3-methyl benzyl)hexahydro-1,4-diazepine (R-3), which is a key intermediate in the synthesis of DAT-582, a potent and selective serotonin-3 receptor antagonist, is described, The precursor of R-3, the (S)-2,3-diaminopropylaminoacetate S-5, was obtained from the chiral triaminopropane derivative R-19. Nucleophilic reaction of the chiral mesylate R-ll with 3-methylbenzylamine gave the racemic 2,3-diaminopropylaminoacetate (+/-)-5 vie the achiral azetidinium cation 12, while the reaction of the N-protected mesylate R-14 produced the desired triamine S-15 but in poor yield, However, reaction of the N-protected mesylate S-18 with a large excess of methylamine proceeded smoothly to afford R-19 in good yield. S-5 was converted into R-3 with >99% enantiomeric excess using an intramolecular reductive cyclization method.
Author MORIE, Toshiya
HARADA, Hiroshi
KATO, Shiro
Author_xml – sequence: 1
  fullname: HARADA, Hiroshi
– sequence: 2
  fullname: MORIE, Toshiya
– sequence: 3
  fullname: KATO, Shiro
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2390871$$DView record in Pascal Francis
BookMark eNqNkUtv1DAUhS1UJKYDK_5AJFi0Ag92HD-yhKG0lSpV4rGObhybeJSxB9sjmv56EmbU2XZzfSV_59zr43N05oM3CL2lZEXLSn3Su3ZViRWlgrxAC8oqiXlZsjO0IITUuGSCvULnKW0IKTmRbIE2V9Y67YzPxY_R594kl4pgi4vvl1jgL8Y_jkN4GDXENvhxgK3zAVO8NbkfB1zhC3bs2__oZW8eoB-7OEEfiwp3Dh7NznmzKm5fo5cWhmTeHM8l-vXt6uf6Bt_dX9-uP99hzTnLWFhJOJSCd0QrZrgStWwV17bTAJ3UVgqqQdRcM90BLQ1QKYzpqlaqttMdW6J3B99dDH_2JuVmE_bRTyMbWgnCKCdTXaIPB0rHkFI0ttlFt4U4NpQ0c5jNFGZTiWYOc6LfHz0haRhsBK9depKUrCZK0pPpX9MGm-ZctXmipj8gslKK8amhcqLV8-m1y5Bd8Ouw93mSfj1INynD75MIYnZ6MPPutOZq3l8eyvyM03UPsTGe_QMaZK64
CODEN CPBTAL
CitedBy_id crossref_primary_10_1021_ol203101s
crossref_primary_10_1021_op010068e
crossref_primary_10_1002_jhet_5570390417
crossref_primary_10_1016_j_tetlet_2009_03_141
crossref_primary_10_1002_chin_199852185
ContentType Journal Article
Copyright The Pharmaceutical Society of Japan
1998 INIST-CNRS
Copyright Japan Science and Technology Agency 1998
Copyright_xml – notice: The Pharmaceutical Society of Japan
– notice: 1998 INIST-CNRS
– notice: Copyright Japan Science and Technology Agency 1998
DBID 1KM
1KN
BLEPL
DTL
FFIDB
IQODW
AAYXX
CITATION
7TK
7TM
7U9
H94
DOI 10.1248/cpb.46.1160
DatabaseName Index Chemicus
Current Chemical Reactions
Web of Science Core Collection
Science Citation Index Expanded
Web of Science - Science Citation Index Expanded - 1998
Pascal-Francis
CrossRef
Neurosciences Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
DatabaseTitle Web of Science
CrossRef
AIDS and Cancer Research Abstracts
Virology and AIDS Abstracts
Neurosciences Abstracts
Nucleic Acids Abstracts
DatabaseTitleList
AIDS and Cancer Research Abstracts
Web of Science
Database_xml – sequence: 1
  dbid: 1KN
  name: Current Chemical Reactions
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/woscc/search-with-editions?editions=WOS.CCR
  sourceTypes:
    Enrichment Source
    Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
Chemistry
EISSN 1347-5223
EndPage 1164
ExternalDocumentID 3133342021
10_1248_cpb_46_1160
2390871
000074883500017
article_cpb1958_46_7_46_7_1160_article_char_en
GroupedDBID ---
.55
2WC
53G
5GY
6J9
AAUGY
ABTAH
ACGFO
ACIWK
ACPRK
ADBBV
AENEX
AFRAH
AI.
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CS3
DIK
DU5
EBS
EJD
F5P
GX1
HH5
JSF
JSH
KQ8
L7B
OK1
P2P
RJT
RZJ
TKC
TR2
VH1
X7M
ZGI
ZY4
1KM
1KN
BLEPL
DTL
GROUPED_WOS_SCIENCE_CITATION_INDEX_EXPANDED
.GJ
29B
3O-
AABQG
BKOMP
E3Z
IQODW
JMI
MOJWN
X7J
XSB
ZE2
AAYXX
CITATION
7TK
7TM
7U9
H94
ID FETCH-LOGICAL-c553t-6f705a265d0c83e58697b85cfdcaad7cf761ca695c3cda12ea176eed4b78bdcd3
ISICitedReferencesCount 4
ISICitedReferencesURI https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=CitingArticles&UT=000074883500017
ISSN 0009-2363
IngestDate Thu Oct 10 16:42:42 EDT 2024
Fri Aug 23 01:31:05 EDT 2024
Sun Oct 29 17:07:07 EDT 2023
Fri Nov 08 20:01:28 EST 2024
Wed Sep 18 05:24:34 EDT 2024
Thu Aug 17 20:25:56 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords intramolecular reductive cyclization
GR38032F
(S)-2,3-diaminopropyl-aminoacetate
(R)-6-aminohexahydro-1,4-diazepine
PREVENTION
5-HT3 RECEPTOR ANTAGONIST
EMESIS
DAT-582
Reaction intermediate
Intramolecular reaction
Chemical reduction
α-Aminoacid
Cyclization
Enantioselectivity
Nitrogen heterocycle
5-HT3 Serotonine receptor
Antagonist
Chemical synthesis
R configuration
Seven membered ring
Language English
License CC BY 4.0
LinkModel OpenURL
LogoURL https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg
MergedId FETCHMERGED-LOGICAL-c553t-6f705a265d0c83e58697b85cfdcaad7cf761ca695c3cda12ea176eed4b78bdcd3
OpenAccessLink https://www.jstage.jst.go.jp/article/cpb1958/46/7/46_7_1160/_article/-char/en
PQID 1460315060
PQPubID 1996362
PageCount 5
ParticipantIDs webofscience_primary_000074883500017CitationCount
crossref_primary_10_1248_cpb_46_1160
proquest_journals_1460315060
jstage_primary_article_cpb1958_46_7_46_7_1160_article_char_en
webofscience_primary_000074883500017
pascalfrancis_primary_2390871
PublicationCentury 1900
PublicationDate 1998-00-00
PublicationDateYYYYMMDD 1998-01-01
PublicationDate_xml – year: 1998
  text: 1998-00-00
PublicationDecade 1990
PublicationPlace TOKYO
PublicationPlace_xml – name: TOKYO
– name: Tokyo
PublicationTitle Chemical & pharmaceutical bulletin
PublicationTitleAbbrev CHEM PHARM BULL
PublicationTitleAlternate Chem. Pharm. Bull.
PublicationYear 1998
Publisher The Pharmaceutical Society of Japan
Pharmaceutical Soc Japan
Maruzen
Japan Science and Technology Agency
Publisher_xml – name: The Pharmaceutical Society of Japan
– name: Pharmaceutical Soc Japan
– name: Maruzen
– name: Japan Science and Technology Agency
References 3) a) Steadman C.J., Talley N.J., Phillips S.F., Mulvihill C., Gastroenterology, 98, A394 (1990
6) Harada H., Morie T., Kato S., J. Chem. Soc., Perkin Trans. 1, 1997, 3219-3225.
5) Yoshida N., Omoya H., Kato S., Ito T., Eur. J. Pharmacol., 216, 435-440 (1992).
1) Kilpatrick G.J., Bunce K.T., Tyers M.B., Med. Res. Rev., 10, 441-475 (1990).
c) Loisy C., Beorchia S., Centonze V., Fozard J.R., Shechter P.J., Tell G.P., Cephalalgia, 5, 79-82 (1985
d) Costall B., Domeney A.M., Kelly M.E., Naylor R.J., Tyers M.B., Br. J. Pharmacol. (Proc. Suppl.), 90, 89P (1987
b) Cunningham D., Pople A., Ford H.T., Hawthorn J., Gazet J.C., Challoner T., Lancet, 1, 1461-1462 (1987
d) Miyata K., Kamato T., Nishida A., Ito H., Yuki H., Yamano M., Tsutsumi R., Katsuyama Y., Honda K., J. Pharmacol. Exp. Ther., 261, 297-303 (1992).
b) Kato S., Harada H., Morie T., J. Heterocyclic Chem., 32, 637-642 (1995
c) Harada H., Morie T., Hirokawa Y., Kato S., Chem. Pharm. Bull., 44, 2205-2212 (1996).
b) Maxton D.G., Haigh C.G., Whorwell P.J., Gastroenterology, 100, A468 (1991
2) a) Leibundgut U., Lancranjan I., Lancet, 1, 1198 (1987
4) a) Jones B.J., Costall B., Domeney A.M., Kelly M.E., Naylor R.J., Oakley N.R., Tyers M.B., Br. J. Pharmacol., 93, 985-993 (1988
7) a) Morie T., Kato S., Harada H., Fujiwara I., Watanabe K., Matsumoto J., J. Chem. Soc., Perkin Trans. 1, 1994, 2565-2569
b) Costall B., Naylor R.J., Tyers M.B., Pharmacol. Ther., 47, 181-202 (1990
c) Prior A., Read N.W., Gut, 31, A1174 (1990
e) Costall B., Domeney A.M., Naylor R.J., Tyers M.B., Br. J. Pharmacol., 92, 881-894 (1987).
c) Andrew P.L.R., Rapeport W.G., Sanger G.J., Trends Pharmacol. Sci., 9, 334-341 (1988).
8) Beaulieu P.L., Schiller P.W., Tetrahedron Lett., 29, 2019-2022 (1988).
STEADMAN C J (BCI:BCI199039017373) 1990; 98
MORIE, T (WOS:A1994PH57200011) 1994
PRIOR, A (WOS:A1990ED16600087) 1990; 31
ANDREWS, PLR (WOS:A1988Q112100012) 1988; 9
KATO, S (WOS:A1995QW37500044) 1995; 32
COSTALL, B (WOS:A1990DR20400003) 1990; 47
MAXTON D G (BCI:BCI199141052087) 1991; 100
Harada, H (WOS:A1996WA39400002) 1996; 44
CUNNINGHAM, D (WOS:A1987H958800005) 1987; 1
LOISY, C (WOS:A1985ALB9400004) 1985; 5
JONES, BJ (WOS:A1988M783800035) 1988; 93
YOSHIDA, N (WOS:A1992JD83500015) 1992; 216
COSTALL, B (WOS:A1987L148000022) 1987; 92
MIYATA, K (WOS:A1992HN73300039) 1992; 261
KILPATRICK, GJ (WOS:A1990ED67800002) 1990; 10
COSTALL B (BCI:BCI198733050701) 1987; 90
HARADA H (WOS:000074883500017.7) 1997
LEIBUNDGUT, U (WOS:A1987H389600016) 1987; 1
BEAULIEU, PL (WOS:A1988N309300004) 1988; 29
References_xml – volume: 93
  start-page: 985
  year: 1988
  ident: WOS:A1988M783800035
  article-title: THE POTENTIAL ANXIOLYTIC ACTIVITY OF GR38032F, A 5-HT3-RECEPTOR ANTAGONIST
  publication-title: BRITISH JOURNAL OF PHARMACOLOGY
  contributor:
    fullname: JONES, BJ
– volume: 44
  start-page: 2205
  year: 1996
  ident: WOS:A1996WA39400002
  article-title: An efficient synthesis of 6-substituted aminohexahydro-1H-1,4-diazepines from 2-substituted aminopropenals
  publication-title: CHEMICAL & PHARMACEUTICAL BULLETIN
  contributor:
    fullname: Harada, H
– volume: 47
  start-page: 181
  year: 1990
  ident: WOS:A1990DR20400003
  article-title: THE PSYCHOPHARMACOLOGY OF 5-HT3 RECEPTORS
  publication-title: PHARMACOLOGY & THERAPEUTICS
  contributor:
    fullname: COSTALL, B
– volume: 90
  start-page: 89P
  year: 1987
  ident: BCI:BCI198733050701
  article-title: THE ANTIPSYCHOTIC POTENTIAL OF GR38032F A SELECTIVE ANTAGONIST OF 5HT-3 RECEPTORS IN THE CENTRAL NERVOUS SYSTEM
  publication-title: British Journal of Pharmacology
  contributor:
    fullname: COSTALL B
– start-page: 2565
  year: 1994
  ident: WOS:A1994PH57200011
  article-title: RING EXPANSION OF NITROGEN-CONTAINING CHLOROMETHYLHETEROALICYCLES VIA AZIRIDINIUM INTERMEDIATES
  publication-title: JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1
  contributor:
    fullname: MORIE, T
– volume: 98
  start-page: A394
  year: 1990
  ident: BCI:BCI199039017373
  article-title: VARIATIONS OF TONE IN THE HUMAN COLON
  publication-title: Gastroenterology
  contributor:
    fullname: STEADMAN C J
– start-page: 3219
  year: 1997
  ident: WOS:000074883500017.7
  publication-title: J CHEM SOC P1
  contributor:
    fullname: HARADA H
– volume: 10
  start-page: 441
  year: 1990
  ident: WOS:A1990ED67800002
  article-title: 5-HT3 RECEPTORS
  publication-title: MEDICINAL RESEARCH REVIEWS
  contributor:
    fullname: KILPATRICK, GJ
– volume: 216
  start-page: 435
  year: 1992
  ident: WOS:A1992JD83500015
  article-title: 5-HT3 RECEPTOR ANTAGONIST EFFECTS OF DAT-582, (R)-ENANTIOMER OF AS-5370
  publication-title: EUROPEAN JOURNAL OF PHARMACOLOGY
  contributor:
    fullname: YOSHIDA, N
– volume: 9
  start-page: 334
  year: 1988
  ident: WOS:A1988Q112100012
  article-title: NEUROPHARMACOLOGY OF EMESIS INDUCED BY ANTI-CANCER THERAPY
  publication-title: TRENDS IN PHARMACOLOGICAL SCIENCES
  contributor:
    fullname: ANDREWS, PLR
– volume: 1
  start-page: 1461
  year: 1987
  ident: WOS:A1987H958800005
  article-title: PREVENTION OF EMESIS IN PATIENTS RECEIVING CYTOTOXIC DRUGS BY GR38032F, A SELECTIVE 5-HT3 RECEPTOR ANTAGONIST
  publication-title: LANCET
  contributor:
    fullname: CUNNINGHAM, D
– volume: 1
  start-page: 1198
  year: 1987
  ident: WOS:A1987H389600016
  article-title: 1ST RESULTS WITH ICS-205-930 (5-HT3 RECEPTOR ANTAGONIST) IN PREVENTION OF CHEMOTHERAPY-INDUCED EMESIS
  publication-title: LANCET
  contributor:
    fullname: LEIBUNDGUT, U
– volume: 32
  start-page: 637
  year: 1995
  ident: WOS:A1995QW37500044
  article-title: SYNTHESIS OF 6-AMINO-1-BENZYL-4-METHYLHEXAHYDRO-1H-1,4-DIAZEPINE
  publication-title: JOURNAL OF HETEROCYCLIC CHEMISTRY
  contributor:
    fullname: KATO, S
– volume: 31
  start-page: A1174
  year: 1990
  ident: WOS:A1990ED16600087
  article-title: REDUCTION OF RECTAL SENSITIVITY AND POSTPRANDIAL MOTILITY BY GRANISETRON, A 5HT3 RECEPTOR ANTAGONIST, IN PATIENTS WITH IRRITABLE-BOWEL-SYNDROME (IBS)
  publication-title: GUT
  contributor:
    fullname: PRIOR, A
– volume: 100
  start-page: A468
  year: 1991
  ident: BCI:BCI199141052087
  article-title: CLINICAL TRIAL OF ONDANSETRON A SELECTIVE 5HT3 ANTAGONIST IN IRRITABLE BOWEL SYNDROME IBS
  publication-title: Gastroenterology
  contributor:
    fullname: MAXTON D G
– volume: 92
  start-page: 881
  year: 1987
  ident: WOS:A1987L148000022
  article-title: EFFECTS OF THE 5-HT3 RECEPTOR ANTAGONIST, GR38032F, ON RAISED DOPAMINERGIC ACTIVITY IN THE MESOLIMBIC SYSTEM OF THE RAT AND MARMOSET BRAIN
  publication-title: BRITISH JOURNAL OF PHARMACOLOGY
  contributor:
    fullname: COSTALL, B
– volume: 261
  start-page: 297
  year: 1992
  ident: WOS:A1992HN73300039
  article-title: ROLE OF THE SEROTONIN-3 RECEPTOR IN STRESS-INDUCED DEFECATION
  publication-title: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
  contributor:
    fullname: MIYATA, K
– volume: 29
  start-page: 2019
  year: 1988
  ident: WOS:A1988N309300004
  article-title: ENANTIOSPECIFIC SYNTHESIS OF D-ALPHA,OMEGA-DIAMINOALKANOIC ACIDS
  publication-title: TETRAHEDRON LETTERS
  contributor:
    fullname: BEAULIEU, PL
– volume: 5
  start-page: 79
  year: 1985
  ident: WOS:A1985ALB9400004
  article-title: EFFECTS ON MIGRAINE HEADACHE OF MDL 72,222, AN ANTAGONIST AT NEURONAL 5-HT RECEPTORS - DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
  publication-title: CEPHALALGIA
  contributor:
    fullname: LOISY, C
SSID ssj0025073
Score 1.5501256
Snippet An efficient and practical method for large scale synthesis of (R)-6-benzyloxycarbonylamino-1-methyl-4-(3-methylbenzyl)hexahydro-1, 4-diazepine (R-3), which is...
An efficient and practical method for large scale synthesis of (R)-6-benzyloxycarbonylamino-1-methyl-4-(3-methyl benzyl)hexahydro-1,4-diazepine (R-3), which is...
Source Web of Science
SourceID proquest
crossref
pascalfrancis
webofscience
jstage
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1160
SubjectTerms (R)-6-aminohexahydro-1, 4-diazepine
(S)-2, 3-diaminopropyl-aminoacetate
Biological and medical sciences
Chemistry
Chemistry, Medicinal
Chemistry, Multidisciplinary
DAT-582
Exact sciences and technology
Heterocyclic compounds
Heterocyclic compounds with several n hetero atoms in the same ring, in separated rings or in fused rings
intramolecular reductive cyclization
Life Sciences & Biomedicine
Medical sciences
Neuropharmacology
Neurotransmitters. Neurotransmission. Receptors
Organic chemistry
Pharmacology & Pharmacy
Pharmacology. Drug treatments
Physical Sciences
Preparations and properties
Science & Technology
Serotoninergic system
Title Efficient Synthesis of (R)-6-Benzyloxycarbonylamino-1-methyl-4-(3-methylbenzyl)hexahydro-1, 4-diazepine. I
URI https://www.jstage.jst.go.jp/article/cpb1958/46/7/46_7_1160/_article/-char/en
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=FullRecord&UT=000074883500017
https://www.proquest.com/docview/1460315060
Volume 46
WOS 000074883500017
WOSCitedRecordID wos000074883500017
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Chemical and Pharmaceutical Bulletin, 1998/07/15, Vol.46(7), pp.1160-1164
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELeqwQMSQnyKwobyUKZNNF3iOHb7wEMZnTY21lEyqW-R7bhqJ2irtpOW_j38odwlaT7EhAovUetcYiW_y33Zd0dIg2slpKTCdo2SNtPwzcnI1TaVhmpwNwTVmDv89ZKfXrMvQ39Yq_0q7Vq6XamWXt-bV_I_qMIY4IpZsv-AbH5TGIDfgC8cAWE4boVxL6n_gKv53-MpWHJZcRGMCrzH_Sb2JzNdg0d-F2u5ULgHXf6cTGfgz2Hj6PiHzWyg9bJ_KiGGC8fmTo7jaAGEiACzgYfWZg72aCsLsm5KG2yqDSD_zMeV6Lgq1_VGvukOup-7iaabgGYeT3Ko-4OzZEtmgKNxribOu0E_ic2Ogb4ITmC2XqEyQNUX8gnXAIqlgg_dJK20IpY7NvUySWdSSewxAV5ymoy8EdVZtDJlSVGSu66bdiX4QyFQhkkOeq5ajLc2VNWy25f98OT64iIMesOgejZV8-DFe4w6WK3gAQVxhhtHz7_la1VgQ4q8Xx8-RJYFCjMfleat2D0Pb8D0x5oOj-dyCZiM0iYqFS_nHjsosXmCp-RJ5qxY3ZTznpGamT4n-1cp0HHTCorkvWXT2reuijro8Qtyk7OnlbOnNRtZB4PDrVjzoMqYhyW2bFplprTOXpLrk15wfGpnrT1s7fveyuYj4fiScj9ydNszfpt3hGr7ehRpKSMslcVdLXnH156OpEuNdAUHc44p0VaRjrxXZGc6m5rXxALKETMdTh01YtRwGWnOIl9J6RoaMVEnjc2LD-dpBZcQPV_AJwR8QsZDxKdOPqag5ETZZ41EWJEJCUV6QPriNLxaEEZ1slfBMr8N9TpOW7h1srvBNsxEyBL9buyy4uD0jTLe-dXJVgNQsh42LnHhYdxtyI6z-v5Y12L15u8zvyWP0jxbDCvukp3V4tbsgaG9Uu8SPv8NAUnVPg
link.rule.ids 315,783,787,4031,27935,27936,27937
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Efficient+Synthesis+of+%28R%29-6-Benzyloxycarbonylamino-1-methyl-4-%283-methylbenzyl%29hexahydro-1%2C+4-diazepine.+I&rft.jtitle=Chemical+%26+pharmaceutical+bulletin&rft.au=HARADA%2C+Hiroshi&rft.au=MORIE%2C+Toshiya&rft.au=KATO%2C+Shiro&rft.date=1998&rft.pub=Japan+Science+and+Technology+Agency&rft.issn=0009-2363&rft.eissn=1347-5223&rft.volume=46&rft.issue=7&rft.spage=1160&rft_id=info:doi/10.1248%2Fcpb.46.1160&rft.externalDBID=NO_FULL_TEXT&rft.externalDocID=3133342021
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-2363&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-2363&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-2363&client=summon